Sensitivity of Targeted Biopsy Within Sydney Protocol for GIM
Sponsored by King Chulalongkorn Memorial Hospital
About this trial
Last updated 4 years ago
Study ID
RP016
Status
Unknown status
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 4 years ago
What is this trial about?
Sensitivity of Targeted Biopsy Within Sydney Protocol by Using Narrow Band Imaging for
Extensive Gastric Intestinal Metaplasia Diagnosis
Objective:
The aim of this study is to evaluate the sensitivity of targeted biopsy within Sydney
protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis
Research design: Diagnosis study
Sample size: 105 cases
Data analysis:
The outcomes will be presented using 2 by 2 tables and if the data are normal distribution
the categorical data will be analysed using McNemar's test
What are the participation requirements?
Inclusion Criteria
- At least 18 year of age
- Suspected GIM by previous tissue pathology
- Able to provide informed consent for participation
Exclusion Criteria
- Previous gastric surgery including gastrectomy and bypass surgery
- Coagulopathy
- Pregnancy
- Active upper GI bleeding